EULAR Epidemiology and Health Services Study Groups
Focus groups within the sphere of musculoskeletal medicine may apply for EULAR endorsement and also support through the Standing Committee on Epidemiology.
EULAR Study Group on Longitudinal Observational Registers and Drug Studies
The aim is to create a platform for methodological, logistic, and scientific collaboration across European Rheumatology drug registers in order to maximise the potential use of the data collected within each register, to maximise the quality of the scientific outputs within and across registers, and to maximise the exchange of experiences across registers. Specifically, the Study Group aims:
- to share experience and best practice across all interested European rheumatology drug registers, extending beyond established registers and beyond biologics registers, through provision of regular open meetings
- to create a mechanism for collaborative investigator-initiated project.
- to provide the infrastructure to enable methods-development in collaborative analysis.
Coordinator and current members : Johan Askling (Sweden, current coordinator), Will Dixon (UK), Kimme Hyrich (UK), Louise Mercer (UK), Joachim Listing (Germany), Angela Zink (Germany), Tore Kvien (Norway), Merete Hetland (Denmark), Piet van Riel (Netherlands), Robert Landewe (Netherlands), Loreto Carmona (Spain), Loza Estabaliz (Spain), Jakub Zavada (Check Republic), Kalle Altonen (Finland), Philippe Ravaud (France), Rotar Ziga (Slovenia), Axel Finckh (Switzerland).
The Study Group is open to anyone interested in collaborative efforts in the field of European Rheumatology registers.
EULAR Study Group for Public Health in RMDs (eumusc.net)
This Study Group evolved from the eumusc.net network of partners, a project supported by the EU and EULAR which completed its work in June 2013. The Study Group intends to continue and expand the work of the eumusc.net in view of promoting and enabling the highest standards of care of RMDs across Europe.
Study group application form